SECreport

Form 4 TherapeuticsMD, Inc. For: Aug 12 Filed by: Milligan John C.K. IV

TherapeuticsMD, Inc.  (TXMD) 
NASDAQ:AMEX Investor Relations: ir.therapeuticsmd.com